peptidylprolyl isomerase A pseudogene 71Genealiases: []
Q-omics provides the consensus-scored PPIAP71 profile across patient tissues and cancer cell-line models. PPIAP71 expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in READ. Among the 18 cancer types available for tumor–normal comparison, PPIAP71 is differentially expressed in 5, with the highest sampling consensus in LUAD. Additionally, PPIAP71 RNA expression shows 7,636 significant protein co-abundance associations, with the highest sampling consensus in GBM. Together, these results highlight READ, LUAD, and GBM as cancer lineages where PPIAP71 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for PPIAP71 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes PPIAP71 survival associations across molecular data types. PPIAP71 RNA expression shows survival associations in the most cancer types (16). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible PPIAP71 RNA expression–survival associations across cancer types. High PPIAP71 expression shows unfavorable associations in READ, LIHC and UVM, but favorable associations in KIRP, UCS and ESCA. The READ Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .005). Together, the overview and detailed table identify READ as the clearest survival context for PPIAP71 RNA expression.
This table summarizes PPIAP71 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 5. The strongest signals are observed in LUAD for RNA.
This table ranks reproducible tumor–normal expression differences for PPIAP71. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. PPIAP71 shows higher tumor expression in LUAD, HNSC, BRCA, READ and COAD. The LUAD box plot shows higher PPIAP71 RNA expression in tumor versus normal tissue (log2 FC = +0.233, t-test p = .007).
This table shows molecular features associated with PPIAP71 in patient tissues and cancer cell lines. In patient samples, PPIAP71 shows the broadest associations at the RNA and protein expression levels, with GBM recurring as the lineage with the largest associated feature set.
